SCHEMBL4130360

SCHEMBL4130360

COC(=O)c1sc2cc(-c3cccc4ccccc34)ccc2c1OCC(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 4/20 0.43
MAPK1 P28482 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 5/20 0.38
PPARG P37231 3/20 0.38
PPARA Q07869 3/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
PPARD Q03181 1/20 0.38
HPGD P15428 4/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 3/20 0.37
GLA P06280 2/20 0.37
GAA P10253 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4118492 0.89 MAPK1 (0.37) MCL1MAPK1LMNAMAPTHPGD
SCHEMBL4119302 0.87 LIPG (0.42) MCL1MAPK1LMNAMAPTCYP2C9
SCHEMBL4126920 0.85 PTPN1 (0.37) MCL1MAPK1LMNAMAPTCYP2C9
SCHEMBL4124207 0.84 MAPT (0.39) MCL1MAPK1LMNAMAPTHPGD
SCHEMBL4131737 0.83 L3MBTL1 (0.41) MAPK1LMNAMAPTHPGDALDH1A1
SCHEMBL4131424 0.83 MAPT (0.37) MAPK1LMNAMAPTHPGDALDH1A1
SCHEMBL4124240 0.83 GABRA1 (0.42) MAPK1LMNAMAPTCYP2C9CYP2C19
SCHEMBL4123046 0.81 EGLN1 (0.40) MAPK1MAPTHPGDALDH1A1KDM4E
SCHEMBL4118848 0.81 NR4A2 (0.40) MAPK1LMNAMAPTHPGDALDH1A1
SCHEMBL4131053 0.80 SMN1; SMN2 (0.43) MCL1MAPK1LMNAMAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048286-A1 Inhibitors of Protein Tyrosine Phosphatase 1B WYETH (US) 2009-02-19 US disclosed
US-20050203081-A1 Inhibitors of protein tyrosine phosphatase 1B WYETH 2005-09-15 US disclosed
WO-2005081960-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B WYETH (US) 2005-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203081-A1 Inhibitors of protein tyrosine phosphatase 1B PTPRS, PTPRO, PTPRM MCL1 1825/4885MAPK1 302/4885LMNA 4856/4885
US-20090048286-A1 Inhibitors of Protein Tyrosine Phosphatase 1B PTPRS, PTPRO, PTPRM MCL1 1825/4885MAPK1 302/4885LMNA 4856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.